TECHBio-Techne
$72.47+37% 1Y
$72.47
$43.2252 weeks$72.62
The financials
Bio-Techne by the numbers
Bio-Techne (TECH) reported revenue of $321M in Q4 2026 (quarter ended Jun 30, 2026), up 1.3% from the same quarter a year earlier. That came with a gross margin of 66%. For the full year FY2026, revenue was $1.22B (−0.4% year on year) and net income $182M. Its largest region in Q4 2026 was United States at $166M, 52% of the disclosed total, well ahead of EMEA Excluding UK at 25%. The next results filing is expected around Nov 4, 2026, the same week as a year ago.
| Income statement | Q4 2026 | Q4 2025 | Change |
|---|---|---|---|
| Revenue | $321M | $317M | +1.3% |
| Gross profit | $211M | $199M | +6.3% |
| Operating income | $74M | −$24M | to a profit |
| Net income | n/a | −$18M | n/a |
| Diluted EPS | $0.35 | −$0.11 | to a profit |
| Geographic | Revenue | Share |
|---|---|---|
| United States | $166M | 52% |
| EMEA Excluding UK | $80M | 25% |
| China | $27M | 8.4% |
| APAC Excluding Greater China | $22M | 6.9% |
| United Kingdom | $14M | 4.5% |
| Rest Of World | $11M | 3.5% |
Business segments
Revenue split by geographic segment, from SEC XBRL filings.
Latest period: Jun 2026Total $321.2M (+3.1%)
Rest Of World grew +17% year on yearUnited States -5.8% year on year
Segment Latestquarter on quarteryear on year
- United States$166.1M$166.1Mquarter on quarter -0.83%year on year -5.8%-0.83%-5.8%
- EMEA Excluding UK$80.3M$80.3Mquarter on quarter +9.3%year on year +14%+9.3%+14%
- China$26.9M$26.9Mquarter on quarter +3.5%year on year +0.03%+3.5%+0.03%
- APAC Excluding Greater China$22.1M$22.1Mquarter on quarter +1.3%year on year +17%+1.3%+17%
- United Kingdom$14.5M$14.5Mquarter on quarter -2.9%year on year -2.2%-2.9%-2.2%
- Rest Of World$11.3M$11.3Mquarter on quarter +46%year on year +17%+46%+17%
On our screens:Stocks with no debt
Biotechnology
The closest names by size in the same industry